Branchenvergleich
|
|
| Boston Scient... | Edwards Lifes... | Becton, Dicki... | IDEXX Laborat... | Nasdaq 100 |
|
Überblick
|
|
|
ISIN
|
| US1011371077 | US28176E1082 | US0758871091 | US45168D1046 | US6311011026 |
|
Marktkapitalisierung
|
|
133,18 Mrd. EUR | 38,11 Mrd. EUR | 60,16 Mrd. EUR | 31,52 Mrd. EUR | - |
|
Anzahl d. umlauf. Aktien
|
|
1,48 Mrd. | 587,9 Mio. | 287,14 Mio. | 81,33 Mio. | - |
|
Dividende je Aktie*
|
|
- | - | 3,80 USD | - | - |
|
Dividendenrendite
|
|
- | - | 1,66% | - | - |
|
KGV
|
|
78,24 | 10,15 | 38,92 | 39,31 | - |
|
KGV (mit verwäss. Erg. / Aktie)*
|
|
71,46 | 10,62 | 41,14 | 38,75 | - |
|
Streubesitz
|
|
- | 83,04% | 77,40% | 57,24% | - |
|
Performance
|
|
|
Börse
|
| NYSE | NYSE | NYSE | NASDAQ | Indices Nasdaq |
|
1 Woche
|
|
+3,10% | +3,36% | +1,75% | -0,80% | +0,46% |
|
1 Monat
|
|
-6,52% | -6,58% | +1,65% | -5,74% | -12,18% |
|
3 Monate
|
|
+11,87% | -2,91% | +2,12% | +3,05% | -8,22% |
|
lfd. Jahr
|
|
+10,26% | -4,51% | +0,87% | +2,38% | -7,36% |
|
1 Jahr
|
|
+46,46% | -23,87% | -3,73% | -20,11% | +8,23% |
|
3 Jahre
|
|
+122,70% | -37,31% | -10,42% | -21,97% | +34,99% |
|
5 Jahre
|
|
+261,53% | +22,48% | 0,00% | +106,35% | +171,29% |
|
Fundamentalkennzahlen
|
| 2024 | 2024 | 2024 | 2024 | - |
|
Rechnungslegung
|
| US GAAP | US GAAP | US GAAP | US GAAP | - |
|
Umsatzerlöse
(in Mio.)
|
|
16.747 USD | 5.439,5000 USD | 20.178 USD | 3.897,5040 USD | - |
|
Umsatzwachstum
|
|
17,61% | -9,41% | 4,16% | 6,46% | - |
|
EBITDA
(in Mio.)
|
|
- | - | - | - | - |
|
Betriebsergebnis
(in Mio.)
|
|
2.603 USD | 1.378,7000 USD | 2.397 USD | 1.128,3370 USD | - |
|
Ergebnis vor Steuern
(in Mio.)
|
|
2.282 USD | 1.548,1000 USD | 2.005 USD | 1.109,8310 USD | - |
|
Konzernjahresüberschuss
(in Mio.)
|
|
1.853 USD | 4.174,6000 USD | 1.705 USD | 887,8670 USD | - |
|
Gewinnwachstum
|
|
18,03% | 197,68% | 19,73% | 5,07% | - |
|
Ergebnis je Aktie
|
|
1,26 USD | 6,98 USD | 5,88 USD | 10,77 USD | - USD |
|
Eigenkapital
(in Mio.)
|
|
22.003 USD | 10.062,9000 USD | 25.890 USD | 1.595,3130 USD | - |
|
Eigenkapitalquote
|
|
55,85% | 77,08% | 45,19% | 48,44% | - |
|
Eigenkapitalrendite
|
|
8,42% | 41,49% | 6,59% | 55,65% | - |
|
Buchwert je Aktie
|
|
14,91 USD | 17,12 USD | 89,55 USD | 19,62 USD | - |
|
Aktiva, gesamt
(in Mio.)
|
|
39.395 USD | 13.055,3000 USD | 57.286 USD | 3.293,4430 USD | - |
|
Gesamtkapitalrendite
|
|
4,70% | 31,98% | 2,98% | 26,96% | - |
|
Cash Flow (lauf. Geschäft.)
(in Mio.)
|
|
3.435 USD | 542,3000 USD | 3.844 USD | 929,0010 USD | - |
* Letztes Geschäftsjahr